We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Livanova | LSE:LIVN | London | Ordinary Share | GB00BYMT0J19 | ORD GBP1.00 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 50.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMLIVN
LivaNova to Host Conference Call for Fourth Quarter 2016 Results
London, January 25, 2017 - LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) ("LivaNova" or the "Company"), a market-leading medical technology company, will host a conference call to discuss its fourth quarter results on Wednesday, March 1, 2017 at 8:00 a.m. Central Time (1:00 pm GMT).
The Company will release its fourth quarter results earlier that morning, before the open of the U.S. financial markets.
A live webcast of the conference call will be available on the Investor Relations section of LivaNova's website at www.livanova.com. To listen to the conference call by telephone, dial 844-239-5285 (if dialing from within the U.S.) or 512-961-6524 (if dialing from outside the U.S.). The conference ID is 40640458. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the webcast. A replay will be available on the LivaNova website for 90 days following the call.
About LivaNova
LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation. LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems. The Company employs approximately 4,600 employees worldwide and is headquartered in London, U.K. With a presence in more than 100 countries, LivaNova operates as three business franchises: Cardiac Surgery, Cardiac Rhythm Management, and Neuromodulation, with operating headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S.), respectively.
LivaNova is listed on NASDAQ and is admitted to the standard listing segment of the Official List of the UK's Financial Conduct Authority and to trading on the London Stock Exchange (LSE) under the ticker symbol "LIVN."
For more information, please visit www.livanova.com, or contact:
Investor Relations and Media
Karen King
Vice President, Investor Relations & Corporate CommunicationsPhone: +1 (281) 228-7262Fax: +1 (281) 218-9332Email: corporate.communications@livanova.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170125005830/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
January 25, 2017 11:15 ET (16:15 GMT)
1 Year Livanova Chart |
1 Month Livanova Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions